Vaccines Europe has called for an EU-wide committee to implement vaccine-specific clinical health technology assessment (HTA) methodologies in a recent position paper. The paper highlights the broader need for the European Commission (EC) to employ a set of common HTA methodologies and tools for vaccines consistent throughout the EU, with the aim of avoiding duplicative efforts and regulatory issues. Vaccines Europe also recommend for European vaccine clinical HTA committee to be established that reflects both relevant stakeholders and the European Centre for Disease Prevention and Control (ECDC) expertise.

Learn more here.

More on: